Signaling Pathways - NOS - PARP - Pyk2 - Calcium-Activated Potassium (KCa) Channels
清除全部
- A8893 Rucaparib (free base)中文名: 瑞卡帕布Target: PARPSummary: PARP抑制剂
- B6345 L-NIO dihydrochlorideTarget: NOSSummary: 一氧化氮(NO)合酶抑制剂
- B6326 Diphenyleneiodonium chloride中文名: 二苯基氯化碘盐Target: NADPH Oxidases|NOS|GPR3Summary: iNOS和eNOS抑制剂,GPR3激动剂
- B6369 7-Nitroindazole中文名: 硝基吲唑Target: NOSSummary: nNOS抑制剂
- B2191 Dequalinium Chloride中文名: 地喹氯铵Target: PKC|Calcium-Activated Potassium (KCa) ChannelsSummary: PKC抑制剂
- A8808 ME0328Target: PARPSummary: PARP抑制剂
- A8345 PF-562271 HClTarget: FAK|Pyk2Summary: FAK/Pyk2抑制剂
- A8320 PF-00562271Target: FAK|Pyk2Summary: 有效的ATP竞争性FAK/Pyk2抑制剂
- A8310 PF-5622711 CitationTarget: FAK|Pyk2Summary: ATP竞争性的FAK抑制剂。
- A5354 Zonisamide中文名: 唑尼沙胺Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: 抗惊厥和机械效应的抗癫痫药